Besides, rolapitant may trigger the ER stress-CHOP-DR5 signaling pathway by targeting the OTUD3-GRP78 axis, enhancing TRAIL induced apoptosis in lung cancer cells (52). Here, HSPA5 is linked to lung carcinoma.